Serum tumor markers in thyroid diseases
The article highlights the role of serum tumor markers in the diagnosis and treatment of thyroid diseases, primarily various forms of cancer. Clinical indications for the prescription and current recommendations for evaluating the results of thyroglobulin, calcitonin, and carcinoembryonic antigen determination are systematized. Prospects for the use of procalcitonin, chromogranin A tests, as well as individual molecular genetic studies are presented.